B
Boundless Bio Inc
NASDAQ:BOLD
Boundless Bio Inc
NASDAQ:BOLD
Price:
1.14
USD
-3.39%
Market Cap:
$25.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Boundless Bio Inc
NASDAQ:BOLD
|
US |
|
P
|
Palram Industries 1990 Ltd
TASE:PLRM
|
IL |
|
M
|
Maison Solutions Inc
NASDAQ:MSS
|
US |
|
GGL Resources Corp.
OTC:GGLXF
|
CA |
|
C
|
Costco Wholesale Corp
LSE:0I47
|
US |
|
S
|
Standard Supply AS
OSE:STSU
|
NO |
|
C
|
CFECapital S de RL de CV
BMV:FCFE18
|
MX |
|
W
|
WK Kellogg Co
NYSE:KLG
|
US |
|
Valeo Pharma Inc
TSX:VPH
|
CA |
|
Appfolio Inc
NASDAQ:APPF
|
US |
|
D
|
Duke Energy Corp
LSE:0ID1
|
US |
|
N
|
Nelly Group AB (publ)
LSE:0O6Z
|
SE |
|
Bald Eagle Gold Corp
XTSX:BIG
|
CA |
|
Geo Holdings Corp
TSE:2681
|
JP |
|
C
|
Capinfo Company Ltd
HKEX:1075
|
CN |
|
Idorsia Ltd
SIX:IDIA
|
CH |
|
Airsculpt Technologies Inc
NASDAQ:AIRS
|
US |
|
Cobalt Blue Holdings Ltd
ASX:COB
|
AU |
|
ODP Corp
NASDAQ:ODP
|
US |
|
I
|
Integrated Rail and Resources Acquisition Corp
F:5A3
|
US |
|
Aperam SA
OTC:APEMY
|
LU |
|
Microsoft Corp
NASDAQ:MSFT
|
US |
Balance Sheet
Balance Sheet Decomposition
Boundless Bio Inc
Boundless Bio Inc
Balance Sheet Decomposition is not available for
Boundless Bio Inc
Boundless Bio Inc
Balance Sheet
Boundless Bio Inc
Boundless Bio Inc
Currency: USD
| Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
34
|
11
|
24
|
27
|
18
|
|
| Cash Equivalents |
34
|
11
|
24
|
27
|
18
|
|
| Short-Term Investments |
39
|
56
|
97
|
126
|
90
|
|
| Other Current Assets |
2
|
1
|
3
|
2
|
2
|
|
| Total Current Assets |
75
|
68
|
124
|
154
|
110
|
|
| PP&E Net |
3
|
8
|
5
|
51
|
47
|
|
| PP&E Gross |
3
|
8
|
5
|
51
|
47
|
|
| Accumulated Depreciation |
1
|
2
|
3
|
4
|
5
|
|
| Long-Term Investments |
35
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
1
|
1
|
1
|
1
|
|
| Total Assets |
114
N/A
|
77
-32%
|
130
+69%
|
206
+59%
|
157
-24%
|
|
| Liabilities | ||||||
| Accounts Payable |
1
|
1
|
2
|
1
|
1
|
|
| Accrued Liabilities |
3
|
6
|
7
|
7
|
11
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
4
|
8
|
9
|
8
|
13
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
3
|
0
|
48
|
46
|
|
| Total Liabilities |
4
N/A
|
11
+167%
|
9
-12%
|
56
+496%
|
58
+5%
|
|
| Equity | ||||||
| Common Stock |
148
|
148
|
248
|
0
|
0
|
|
| Retained Earnings |
41
|
87
|
136
|
201
|
260
|
|
| Additional Paid In Capital |
3
|
5
|
9
|
352
|
358
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
110
N/A
|
66
-40%
|
121
+82%
|
151
+25%
|
99
-35%
|
|
| Total Liabilities & Equity |
114
N/A
|
77
-32%
|
130
+69%
|
206
+59%
|
157
-24%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
22
|
22
|
22
|
22
|
22
|
|
Switch to:
Switch to:
See Also
Discover More
